Literature DB >> 17643560

Meningitis epidemics in Africa: a brief overview.

Rémy Teyssou1, Erwan Muros-Le Rouzic.   

Abstract

Every year, meningococcal meningitis causes thousands of deaths within the meningitis belt in sub-Saharan African countries. Large epidemic waves occur with a periodicity of 5-12 years. The waves do correspond to molecular changes in the expression of capsular or subcapsular antigens, which allow the bug to spread in susceptible populations. Serogroup A remains the major killer, even if in 2002, serogroup W135 ST-11 emerged in Burkina Faso, causing an important epidemic. However, the surveillance in the following years has showed a decrease in the W135 incidence and a clear predominance of serogroup A. Moreover, a new serogroup A strain belonging to ST-2859 seems to emerge and does represent a new threat for the coming seasons. In a vaccine perspective, and especially in the context of the development of an A conjugate vaccine; it is the key to strengthen the surveillance systems and to include molecular epidemiology as a tool for monitoring the molecular evolution of Neisseria meningitidis in Africa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643560     DOI: 10.1016/j.vaccine.2007.04.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

Review 1.  Invasive meningococcal disease in the 21st century—an update for the clinician.

Authors:  Rachel Dwilow; Sergio Fanella
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

Review 2.  Review of meningococcal vaccines with updates on immunization in adults.

Authors:  Yorgo C Zahlanie; Moza M Hammadi; Soha T Ghanem; Ghassan S Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

Review 3.  Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™).

Authors:  Jamie D Croxtall; Sohita Dhillon
Journal:  Drugs       Date:  2012-12-24       Impact factor: 9.546

4.  Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Authors:  L Agier; A Deroubaix; N Martiny; P Yaka; A Djibo; H Broutin
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

5.  Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.

Authors:  Sara Thulin Hedberg; Hans Fredlund; Pierre Nicolas; Dominique A Caugant; Per Olcén; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

6.  Disease-associated Neisseria meningitidis isolates inhibit wound repair in respiratory epithelial cells in a type IV pilus-independent manner.

Authors:  Xiaoyun Ren; Joanna K MacKichan
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

7.  Temporal analysis of the incidence of meningitis in the Tehran metropolitan area, 1999-2005.

Authors:  Alireza Mosavi-Jarrahi; Abdolreza Esteghamati; Freshteh Asgari; Mohammadali Heidarnia; Yasamin Mousavi-Jarrahi; Mohammadmehdi Goya
Journal:  Popul Health Metr       Date:  2009-12-23

8.  Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.

Authors:  Sara Tartof; Amanda Cohn; Félix Tarbangdo; Mamoudou H Djingarey; Nancy Messonnier; Thomas A Clark; Jean Ludovic Kambou; Ryan Novak; Fabien V K Diomandé; Isaïe Medah; Michael L Jackson
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

9.  The role of environmental transmission in recurrent avian influenza epidemics.

Authors:  Romulus Breban; John M Drake; David E Stallknecht; Pejman Rohani
Journal:  PLoS Comput Biol       Date:  2009-04-10       Impact factor: 4.475

10.  Relationships between climate and year-to-year variability in meningitis outbreaks: a case study in Burkina Faso and Niger.

Authors:  Pascal Yaka; Benjamin Sultan; Hélène Broutin; Serge Janicot; Solenne Philippon; Nicole Fourquet
Journal:  Int J Health Geogr       Date:  2008-07-02       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.